Uncategorized
Eleven Biotherapeutics reports $6.1 million loss in first quarter
Eleven Biotherapeutics reported a net loss of $6.1 million, or $0.25 per share, in the first quarter of 2017 compared with a net loss of $7.6 million, or $0.39 per share, in the same period of 2016. The company had revenues of $0.4 million in the first quarter compared with $0.2 million last year, according to a press release.